NP21716_CordBlood-E-book_2026-05-27 - Flipbook - Page 5
Cord blood bene昀椀ts at-a-glance
TRANSPLANT AVAI LAB I LIT Y FOR
MORE PATI ENTS
Cord blood’s unique nature allows for greater
matching 昀氀exibility. This extends the availability of
transplant to more patients, including those who
are ethnically diverse or pediatric patients.
SPEED TO TRANSPLANT
For diseases in which speed to transplant is critical,
cord blood units (CBUs) allow for rapid utilization. CBUs are
cryopreserved, typed and fully characterized. Therefore,
transplant centers can typically acquire a CBU faster than
marrow or PBSC from an unrelated adult donor.
CH RON IC G RAF T-VERSUS-HOST DISEASE
(GVH D) I NCI DENCE
G RAF T-VERSUS-LEU KEM IA EFFECT
Chronic GVHD is a well-known complication after
allogeneic transplant that can impact patient outcomes
and quality of life. Research has shown that patients who
receive cord blood as a graft source experience a lower
incidence of chronic GVHD.
Patients with acute leukemias who have minimal residual
disease pre-transplant may bene昀椀t from cord blood.
Published research shows evidence that graft-versus
leukemia effects seem to be stronger with cord blood
than other donor sources.
5
